chevron_leftBack
As of 19 June 2026, Xcell Therapeutics Inc. has a market cap of $20.1M USD, ranking #37070 globally and #2353 in South Korea.
It ranks #3328 in the Healthcare sector, and #651 in the Biotechnology industry.
Key Stats
Market Cap
$20.1MUSD
30.66B KRW
Enterprise Value
$19.37MUSD
29.24B KRW
Revenue (TTM)
$1.28MUSD
1.95B KRW
EBITDA (TTM)
-$6.06MUSD
-9.15B KRW
Net Income (TTM)
-$7.16MUSD
-10.93B KRW
PS Ratio
15.7
PB Ratio
4.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
Founded
2015
Website
xcell.co.kr/kor/
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -5.3% | 8.6% | 22% | 9.7% | -21% | -53% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
373110
(주)엑셀세라퓨틱스
ISIN: KR7373110006
Shares Out.:
Shares Outstanding:
17.294M1
Shares Float:
14.063M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1,679 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Xcell Therapeutics Inc.
Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 207940
|
$44.7B
222K%
68.19T KRW
|
35.5
|
|
KRX: 068270
|
$28.03B
139K%
42.76T KRW
|
43.8
|
|
KRX: 196170
|
$13.33B
66K%
20.33T KRW
|
146.6
|
|
KRX: 028300
|
$5.49B
27K%
8.37T KRW
|
-
|
|
KRX: 087010
|
$3.98B
20K%
6.07T KRW
|
-
|
|
KRX: 302440
|
$2.25B
11K%
3.42T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
907K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
795K%
|
19.0
|
|
EBR: ARGX
|
$47.76B
237K%
41.39B EUR
|
39.9
|
|
ASX: CSL
|
$42.44B
211K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.29B
210K%
33.71B CHF
|
37.2
|
|
NASDAQ: NTRA
|
$27.6B
137K%
|
-
|
chevron_leftBack